We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Follow-on biologics in Canada: a look at the new draft guidelines
  • Torys LLP
  • Canada
  • May 27 2008

Health Canada has released a draft guidance document entitled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”


Changes in the regulation of energy drinks in Canada
  • Torys LLP
  • Canada
  • October 18 2011

On October 6, 2011, Health Canada announced its decision to begin regulating most energy drinks as foods


Ontario court confirms generic drug manufacturers not entitled to unjust enrichment
  • Torys LLP
  • Canada
  • January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott


Canada's approach to functional foods
  • Torys LLP
  • Canada
  • April 21 2010

Today’s diet- and health-conscious environment has led to a proliferation of functional food marketing claims that advertise the specific health-enhancing characteristics of a food product


Canada proposes amending the Food and Drugs Act and creating consumer product safety legislation
  • Torys LLP
  • Canada
  • May 2 2008

On April 8, 2008, the federal government tabled legislation in the House of Commons to amend the Food and Drugs Act and to introduce new consumer product safety legislation in Canada


Amendments to the Patented Medicines (Notice of Compliance) Regulations now in force
  • Torys LLP
  • Canada
  • June 13 2008

On June 12, 2008, amendments to the Patented Medicines (Notice of Compliance) Regulations (commonly referred to as the “PM(NOC) Regulations”) came into force


Ontario case on product liability shows the immense scope of a class action trial
  • Torys LLP
  • Canada
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial


Product liability litigation: bar raised for class action certification?
  • Torys LLP
  • Canada
  • May 10 2012

In a decision released May 7, 2012, Justice Caroline Horkins of the Superior Court of Ontario has refused to certify a proposed class proceeding in a pharmaceutical product liability claim (Martin et al. v. Astrazeneca Pharmaceuticals PLC et al


Federal Court of Canada grants data protection to an old medicinal ingredient
  • Torys LLP
  • Canada
  • February 14 2012

In a recent decision Celgene Inc. v. Canada (Minister of Health) the Federal Court of Canada declared that a drug containing a previously approved medicinal ingredient is nevertheless subject to data protection


Producers to manage pharmaceuticals and sharps returned by consumers
  • Torys LLP
  • Canada
  • November 2 2012

On October 1, 2012, Collection of Pharmaceuticals and Sharps Responsibilities of Producers regulation (O. Reg. 29812) came into force